GYRE THERAPEUTICS, INC. (GYRE) has 9 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 4, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 4, 2026 filed Aug. 3, 2026 | Weston Claire Director | $0 | 40,000 | 0% | No | |
|
|
||||||
| Aug. 4, 2026 filed Aug. 3, 2026 | Kirkby Maxwell Director | $0 | 40,000 | 0% | No | |
|
|
||||||
| June 30, 2026 filed June 10, 2026 | Carmichael Gordon Director | $0 | 40,000 | 0% | No | |
|
|
||||||
| June 30, 2026 filed June 10, 2026 | Epstein David M. Director | $0 | 40,000 | 0% | No | |
|
|
||||||
| June 30, 2026 filed June 10, 2026 | Parry Renate Director | $0 | 40,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free